School of Cancer Sciences

Dr Giulia Tesini

  • Affiliate- C Braconi (School of Cancer Sciences)

email: Giulia.Tesini@gla.systa-s.com

WWCRC, Garscube Campus, G61 1BN

Import to contacts

Publications

List by: Type | Date

Jump to: 2026 | 2025
Number of items: 2.

2026

Tesini, G. et al. (2026) IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancers. JHEP Reports, (doi: 10.1016/j.jhepr.2026.101899) (In Press)

2025

Tesini, Giulia, Ibrahim, Halima, Rimassa, Lorenza and Braconi, Chiara ORCID logoORCID: https://orcid.org/0000-0003-4835-1259 (2025) Evolving precision: updates in targeted therapy for cholangiocarcinoma. Hepatology, (doi: 10.1097/HEP.0000000000001541) (PMID:40982790) (Early Online Publication)

This list was generated on Tue Jun 9 19:57:29 2026 BST.
Jump to: Articles
Number of items: 2.

Articles

Tesini, G. et al. (2026) IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancers. JHEP Reports, (doi: 10.1016/j.jhepr.2026.101899) (In Press)

Tesini, Giulia, Ibrahim, Halima, Rimassa, Lorenza and Braconi, Chiara ORCID logoORCID: https://orcid.org/0000-0003-4835-1259 (2025) Evolving precision: updates in targeted therapy for cholangiocarcinoma. Hepatology, (doi: 10.1097/HEP.0000000000001541) (PMID:40982790) (Early Online Publication)

This list was generated on Tue Jun 9 19:57:29 2026 BST.